Pharmacology of competitive inhibitors of HMG-CoA reductase.
Corsini
A
A
Institute of Pharmacological Sciences, University of Milan, Italy.
Maggi
F M
FM
Catapano
A L
AL
D000818:Animals; D000924:Anticholesteremic Agents / Q000494:pharmacology*; D001161:Arteriosclerosis / Q000378:metabolism / Q000517:prevention & control; D002417:Cattle; D002478:Cells, Cultured / Q000187:drug effects; D002642:Chick Embryo; D002784:Cholesterol / Q000096:biosynthesis* / Q000097:blood; D006224:Cricetinae; D004285:Dogs; D006168:Guinea Pigs; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D050356:Lipid Metabolism; D008055:Lipids / Q000097:blood; D008074:Lipoproteins / Q000187:drug effects; D008148:Lovastatin / Q000031:analogs & derivatives / Q000494:pharmacology; D008798:Mevalonic Acid / Q000378:metabolism; D051379:Mice; D009928:Organ Specificity; D011817:Rabbits; D051381:Rats; D019821:Simvastatin
D000924:Anticholesteremic Agents; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D008055:Lipids; D008074:Lipoproteins; D002784:Cholesterol; D008148:Lovastatin; D019821:Simvastatin; D008798:Mevalonic Acid